Molecular Templates Announces Partial Clinical Hold for : co

Partial hold based on previously disclosed cardiac events at 50 mcg/kg cohort; FDA to review safety data in lower dose cohorts...

Related Keywords

Texas , United States , Roger Waltzman , Drug Administration , Nasdaq , Molecular Templates Inc , Molecular Templates , Multiple Myeloma , Very Good Partial Response , Chief Medical Officer , Shiga Like Toxin , Private Securities Litigation Reform Act , Safe Harbor , Molecular Template , Nasdaq Mtem , Nc ,